IMB Dx, Inc. (KOSDAQ:461030)
South Korea
· Delayed Price · Currency is KRW 9,470.00
+210.00 (2.27%)
Apr 1, 2025, 3:30 PM KST
IMB Dx Market Cap
IMB Dx has a market cap or net worth of 129.80 billion as of April 1, 2025.
Market Cap
129.80B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9,470.00
Market Cap Chart
Since April 3, 2024, IMB Dx's market cap has decreased from 503.73B to 129.80B, a decrease of -74.23%. That is a compound annual growth rate of -74.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 129.80B | -13.05% |
| Dec 30, 2024 | 149.29B | -70.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.66T |
| Celltrion | 38.03T |
| ALTEOGEN | 18.79T |
| Yuhan | 8,537.79B |
| SK Biopharmaceuticals | 7,893.98B |
| HLB Co., Ltd. | 7,500.72B |
| Sam Chun Dang Pharm. | 3,930.51B |
| PharmaResearch | 3,506.51B |